Tianjin Chase Sun Pharmaceutical Co.,Ltd announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 2,782.174 million compared to CNY 2,287.734 million a year ago. Operating income was CNY 345.806 million compared to CNY 418.889 million a year ago. Net income was CNY 343.775 million compared to CNY 350.281 million a year ago. Basic earnings per share from continuing operations was CNY 0.11 compared to CNY 0.12 a year ago.